1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Foradil: new trials by email Literature Review of Foradil trials Research Report on Foradil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD) Formoterol, Placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Chiesi Farmaceutici S.p.A. | 54 | 2004-09-01 | 2020-07-31 |
Pulmonary Disease, Chronic Obstructive (1)
Chiesi Farmaceutici S.p.A. (1)
Italy (1)
Carlo Mereu, MD (1) · Gennaro D'Amato, MD (1) · Giorgio Canonica, MD (1) · Giorgio Scano, MD (1) · Giovanni Barisione, MD (1) · Leonardo Fabbri, MD (1) · Pierluigi Paggiaro, MD (1) · Roberto Dal Negro, MD (1) · Vito Brusasco, MD, PhD (1)